Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon (eBook)

Published on: 
,
BioPharm International, BioPharm International-03-15-2020, Volume 2020 eBook, Issue 2
Pages: 36-46

This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.

Pharmacopoeia Compliance Series

Compliance with requirements published by pharmacopoeias around the world is a legal and regulatory requirement in those countries and regions in which the pharmacopoeia is applicable.

This final article in the series has two purposes: to summarize all the considerations that go into a company’s compendial affairs program and to look ahead at topics that will likely result in further evolution in the pharmacopoeias around the world.

This article is part of a series that will be published in 2019–2020. View all articles in this series.

Advertisement

Read this article in BioPharm International’s March 2020 Regulatory Sourcebook.

Article Details

BioPharm International
eBook: Regulatory Sourcebook, March 2020
March 2020
Pages: 36–46

Citation

When referring to this article, please cite it as J.M. Wiggins and J.A. Albanese, “Pharmacopoeia Compliance: Putting It All Together; What Is on the Horizon," BioPharm International Regulatory Sourcebook eBook (March 2020).